| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/01/1997 | WO1997015666A1 Therapeutic antiangiogenic compositions and methods |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015590A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 05/01/1997 | WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 05/01/1997 | WO1997015269A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates |
| 05/01/1997 | CA2233882A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | CA2232241A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | CA2229617A1 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation |
| 05/01/1997 | CA2207846A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 05/01/1997 | CA2205534A1 Method, compositions and kits for increasing the bioavailability of pharmaceutical agents |
| 05/01/1997 | CA2188634A1 1ó,26 dihydroxy-d-homo-vitamin d3 |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 04/30/1997 | CN1148855A Novel spiro [indole-pyrrolidine]derivatives as melatoninergic agonists, method for preparing same and use thereof as drug |
| 04/30/1997 | CN1148851A Dihydodibenzo isoquinolines diketone |
| 04/30/1997 | CN1148805A Method for stabilizing duocarmycin derivatives |
| 04/30/1997 | CN1148590A Sulfuryl or sulfinyl benzoyl guanidine derivative |
| 04/29/1997 | US5625061 Graft=glycinamide riboncleotide formyl transferase |
| 04/29/1997 | US5625050 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
| 04/29/1997 | US5625031 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein |
| 04/29/1997 | US5624957 Retinoid active compounds |
| 04/29/1997 | US5624949 Protein kinase C inhibitors |
| 04/29/1997 | US5624924 Quinobenzothiazine antineoplastic agents |
| 04/29/1997 | US5624919 Trans platinum (IV) complexes |
| 04/29/1997 | US5624908 Antineoplastic compositions |
| 04/29/1997 | US5624830 Selectivity killing mammalian host cells in vitro |
| 04/29/1997 | US5624827 DNA sequences encoding the plant toxin gelonin |
| 04/29/1997 | US5624820 Episomal expression vector for human gene therapy |
| 04/29/1997 | CA2065501C Preparation process of ginkgolide b from ginkgolide c |
| 04/24/1997 | WO1997014966A1 Method of activating a novel ligand regulatory pathway |
| 04/24/1997 | WO1997014808A2 Herpesvirus vectors and their uses |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
| 04/24/1997 | WO1997014715A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | WO1997014683A2 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/24/1997 | WO1997014670A1 Lignans, a process for their production and pharmaceutical compositions and uses thereof |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997014428A1 Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014421A1 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum |
| 04/24/1997 | WO1997014306A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1997009348A3 Orphan receptor |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/24/1997 | WO1997007784A3 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 04/24/1997 | WO1996040055A3 Biological agent compositions |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 04/24/1997 | CA2235245A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | CA2234884A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | CA2234877A1 Herpesvirus vectors and their uses |
| 04/24/1997 | CA2232609A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769296A1 Use of isoxazole- and crotonamide derivatives for the manufacture of a medicament for the treatment of cancers |
| 04/23/1997 | EP0769147A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0769012A1 Tetracyclic derivatives and their use as antitumour agents |
| 04/23/1997 | EP0768898A1 Cascade-polymer complexes and methods of producing the same |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768889A1 Cancer therapy using lymphotoxin |
| 04/23/1997 | EP0768885A1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 04/23/1997 | EP0768877A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 04/23/1997 | EP0768876A1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 04/23/1997 | EP0768869A1 Factor to grow tissue ex vivo |
| 04/23/1997 | EP0768821A1 pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
| 04/23/1997 | EP0626942B1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 04/23/1997 | EP0624196B1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 04/23/1997 | CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines |
| 04/23/1997 | CN1148343A Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 04/23/1997 | CN1148341A Oral liquid alendronate formulations |
| 04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |
| 04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
| 04/22/1997 | US5622975 Prophylaxis or treatment of cardiovascular disorders such as atherosclerosis, restenosis, inflammation, or malignant invasion |
| 04/22/1997 | US5622963 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 04/22/1997 | US5622962 Prostate cancer, skin disorders, baldness |
| 04/22/1997 | US5622961 5α-reductase inhibitors |
| 04/22/1997 | US5622953 1-amino-3-phenoxy propane derivatives as modulator agents and their applications |
| 04/22/1997 | US5622946 Radiation sensitization using texaphyrins |
| 04/22/1997 | US5622936 Complex of sugar with a phosphorus amide |
| 04/22/1997 | US5622929 Anthracycline antibiotic; antitumor agent binds with a target cell |
| 04/22/1997 | US5622721 Dosage forms of risedronate |
| 04/17/1997 | WO1997013854A1 Pilosulin 2 |
| 04/17/1997 | WO1997013787A1 Vegf-binding polypeptide |
| 04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
| 04/17/1997 | WO1997013776A2 Novel amine derivatives of epipodophyllotoxin 2', 3'-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer |
| 04/17/1997 | WO1997013771A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/17/1997 | WO1997013529A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013415A1 Therapeutic diet for dogs with lymphoma |
| 04/17/1997 | WO1997005870A3 Use of griseofulvin for inhibiting the growth of cancers |
| 04/17/1997 | WO1997003701A3 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |